Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Failure To Publish SCD-HeFT Results By CMS Deadline Will Delay ICD Decision

This article was originally published in The Gray Sheet

Executive Summary

CMS will forego issuing a national coverage determination expanding ICD coverage, unless the SCD-HeFT trial results are published in a peer-reviewed journal prior to the Dec. 28 deadline

You may also be interested in...



CMS Proposes Not To Expand ECP Coverage, But Vasomedical Stays Hopeful

Vasomedical is counting on an impending journal publication to alter CMS' proposed decision not to expand coverage of external counterpulsation therapy for treating additional cardiac conditions

CMS Proposes Not To Expand ECP Coverage, But Vasomedical Stays Hopeful

Vasomedical is counting on an impending journal publication to alter CMS' proposed decision not to expand coverage of external counterpulsation therapy for treating additional cardiac conditions

ICD coverage update

CMS releases 1lists of ICD registry hypotheses and data elements in advance of its final rule, which will outline implantable defibrillator coverage registry requirements, to "allow time for the public to become familiar with the data elements and prepare for future data collection efforts." The agency originally had planned to issue a new ICD Medicare coverage policy Dec. 28, including the registry requirements. However, CMS was forced to issue a 2decision maintaining the current coverage policy because results of Medtronic's SCD-HeFT clinical trial, upon which the new decision would be based, have yet to be published in a peer-reviewed journal. The agency has pledged to open reconsideration of the policy as soon as SCD-HeFT is published (3"The Gray Sheet" Dec. 20, 2004, p. 11)...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT021340

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel